Database ID: USAS151  Registry file: S15/286/3  Region: AM

  • Contact information
  • Summary table of centre capabilities
  • Technical capabilities of centre sorted by disease/pathogen
  • Quality assurance programme


  • Contact Information:
      WHO CC Title:

    WHO Collaborating Centre for Applied Biosafety Programmes and Research

      Institution: National Institutes of Health
    Division of Safety, Office of Research Services
      Address: 31 Center Drive MSC 2260
    Bethesda, MD 20892-2260
      Country: USA
      Principle Investigator: Dr Deborah Wilson & Dr Robert Ostrowski Wilson & Ostrowski
      Telephone: +1 301 496-2960 / 496-1357
      Fax: +1 301 402-0313
      Email: dw109u@nih.govwilsodeb@ors.od.nih.gov
      Contact 1: R.J. Ostrowski, Deputy Director, Div. of Safety
    Tel. 1 301 496 1357 Fax. 1 301 402 0316
    E-mail. ostrowsr@mail.nih.gov
      Contact 2: Prev PI - retired
    Professor Robert W. McKinney
    Email: McKinneyR@desspb.od.nih.gov
    Tel +1 301 496-1357 Fax +1 301 402-0316
      Internet Website: www.nih.gov/od/ors/ds
      WHO information: WHO designation information
      Publications:
     
         
    WHO focal points at headquaters and regional office:
        HQ Focal Point: Dr N. Previsani  
     
    Displayed centre capabilities: Summary table of center capabilities
    Technical capabilities of centre sorted by disease/pathogen
    Quality assurance programme

       
    Summary table of centre capabilities
    This table shows the list of diseases/pathogens studied at the selected collaborating center and the activity areas covered - diagnostics, reagents, surveillance and training. The numbers indicate the number of techniques/activities carried out for each disease/pathogen/subject area.

    Disease Pathogen Name
    Click on the disease to view details
    Speciality area Nb diagnostics Nb reagents Nb surveillance Nb training
    Biosafety        

    Disease/Pathogen/subject area glossary
    Technical capabilities glossary

    Technical capabilities of centre sorted by disease/pathogen
     

    Biosafety

  • Training

  •          Capacity building activities
          
           
  • In country training, site visits, lab strengthening (On site training)
      On site training in Biosafety training in Buenos Aires (Argentina) and Bogota (Colombia)
  •        
  • In country training, site visits, lab strengthening (Site visit)
      Site visits to the Oswaldo Cruz Institute to consult on the design and operating practices for a Biosafety Level 3 Laboratory

  •          Training of trainees at CC
          
           
  • Training at centre    
  •        
  • Training in Biosafety issues  
      Laboratory Biosafety, Bloodborne pathogens.
  •  
     
        Back to top
    Quality Assurance Programme
      Internal Quality Control Programme
      Do you have an internal quality control programme? No
      Are lab data/outcomes recorded regulary and available for review? No
      Is there systematic recording and review of corrective action? No
      Internal control components:  
          Assays:
            - Standards and established control criteria: No
            - Performance monitoring (interassay comparisons): No
          Equipment:
     
          - Performance monitoring:
    No
     
          - Preventive maintenance programme:
    No
          Inventory programmes : No
          Media and reagent quality control: No
          Procedure manuals : No
         
      Description of Internal Quality Control Programme
    External quality control programme: No
      Participation in WHO QA programme: No
      Standardization / Evaluation activities: No